Effect of TNF-α antisense oligomers on cytokine production by primary murine alveolar macrophages

Antisense and Nucleic Acid Drug Development

Volumn 8, Issue 3, 1998, Pages 199-205

  Taylor, Margaret Flynn ^a,d   Weller, Dwight D ^b   Kobzik, Lester ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Antivirals Inc   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Sequitur Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGOMER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; DOSE RESPONSE; FEMALE; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; START CODON;

EID: 0031828692     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1998.8.199     Document Type: Article

References (11)

1. AGGARWAL, B.B., SCHWARZ, L., HOGAN, M.E., and RANDO, R.F. (1996). Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. Cancer Res. 56, 5156-5164.
2. 2 by P388D1 cells. J. Biol. Chem. 268, 21875-21882.
3. BENNETT, CF., CONDON, T.P., GRIMM, S., CHAN, H., and CHIANG, M. (1994). Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152, 3530-3540.
4. BEUTLER, B., and CERAMI, A. (1989). The biology of cachectin/ TNF - A primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655.
5. DENIS, M., CORMIER, Y., FOURNIER, M., TARDIF, J., and LA VIOLETTE, M. (1991). Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am. J. Respir. Cell Mol. Biol. 5, 477-483.
6. GRIGORIEV, M., PRESEUTH, D., ROBIN, P., HEMAR, A., SAISON-BEHMOARAS, T., DAUTRY-VARSAT, A., THUONG, N.T., HÉLÈNE, C. and HAREL-BELLAN, A. (1992). A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional represser via inhibition of NFκB binding to IL-2 receptor - A regulatory sequence. J. Biol. Chem. 267, 3389-3395.
7. HARTMANN, G., KRUG, A., EIGLER, A., MOELLER, J., MURPHY, J., ALBRECHT, R., and ENDRES, S. (1996). Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 6, 291-299.
8. ROJANASAKUL, Y., WEISSMAN, D.N., SHI, X., CASTRANOVA, V., MA, J.K.H., and LIANG, W. (1997). Antisense inhibition of silica-induced tumor necrosis factor in alveolar macrophages. J. Biol. Chem. 272, 3910-3914.
9. ROTEN, R., MARKERT, M., FEIHL, F., SCHALLER, M., TAGAN, M., and PERRET, C. (1991). Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 143, 590-592.
10. WARREN, J.S., YABROFF, K.R., REMICK, D.G., KUNKEL, S.L., CHENSUE, S.W., KUNKEL, R.G., JOHNSON, K.J., and WARD, P.A. (1989). Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84, 1873-1882.
11. YAHATA, N., KAWAI, S., HIGAKI, M., and MIZUSHIMA, Y. (1996). Antisense phosphorothioate oligonucleotide inhibits interleukin Ibeta production in the human macrophage-like cell line, U937. Antisense Nucleic Acid Drug Dev. 6, 55-61.